These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 51086
21. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2. Nakayama E, Uenaka A, Stockert E, Obata Y. Cancer Res; 1984 Nov; 44(11):5138-44. PubMed ID: 6091870 [Abstract] [Full Text] [Related]
29. Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells. Nicolin A, Franco P, Testorelli C, Goldin A. Cancer Res; 1976 Jan 01; 36(1):222-7. PubMed ID: 1248001 [Abstract] [Full Text] [Related]
30. Subcellular representation of murine thymus-leukemia (TL) antigens in phenotypically TL+ and TL- cells. Smith SR, Lamm ME, Powers ML, Boyse EA. J Immunol; 1974 Oct 01; 113(4):1098-106. PubMed ID: 4415973 [No Abstract] [Full Text] [Related]
31. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay. Fuji H, Mihich E. Cancer Res; 1975 Apr 01; 35(4):946-52. PubMed ID: 1090366 [Abstract] [Full Text] [Related]
32. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera. Peters CJ, Theofilopoulos AN. J Immunol; 1977 Sep 01; 119(3):1089-96. PubMed ID: 70469 [Abstract] [Full Text] [Related]
33. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR. J Immunol; 1983 Dec 01; 131(6):3078-84. PubMed ID: 6605998 [Abstract] [Full Text] [Related]
34. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones. Jones B, Tite JP, Janeway CA. J Immunol; 1986 Jan 01; 136(1):348-56. PubMed ID: 2415625 [Abstract] [Full Text] [Related]
35. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response. Ting CC, Kirchner H, Rodrigues D, Park JY, Herberman RB. J Immunol; 1976 Jan 01; 116(1):244-52. PubMed ID: 54388 [Abstract] [Full Text] [Related]
36. Chromosomally depleted interspecific hybrid cell clones selected with cytotoxic antisera: utilization in the study of control of murine leukemia virus host-range. Collins JJ, Destree AT, Marshall CJ, Bernstein A, Macpherson IA. J Supramol Struct; 1976 Jan 01; 4(1):71-88. PubMed ID: 176536 [Abstract] [Full Text] [Related]
37. Thymus-leukemia antigen interacts with T cells and self-peptides. Sharma P, Joyce S, Chorney KA, Griffith JW, Bonneau RH, Wilson FD, Johnson CA, Flavell RA, Chorney MJ. J Immunol; 1996 Feb 01; 156(3):987-96. PubMed ID: 8558026 [Abstract] [Full Text] [Related]
38. Selective cell surface expression of thymus leukemia antigen during S phase of the cell cycle. Williams JL, Pickering JW, Wolcott M. J Immunol; 1979 Mar 01; 122(3):1121-5. PubMed ID: 312816 [Abstract] [Full Text] [Related]
39. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. Manjunath R, Graziano RF, Green WR. J Immunol; 1986 Mar 15; 136(6):2271-9. PubMed ID: 3005407 [Abstract] [Full Text] [Related]
40. Serological analysis of H-2 antigens expression on the cell surface of drug- and lectin-resistant mouse tumor cells. Opolski A, Duś D, Radzikowski C. Arch Immunol Ther Exp (Warsz); 1986 Mar 15; 34(1):21-34. PubMed ID: 3778114 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]